The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Breast Cancer Screening-Global Market Insights and Sales Trends 2025

Breast Cancer Screening-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1824374

No of Pages : 95

Ask Your Query

Synopsis

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

The global Breast Cancer Screening market size is expected to reach US$ 85 million by 2029, growing at a CAGR of 8.4% from 2023 to 2029. The market is mainly driven by the significant applications of Breast Cancer Screening in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Breast Cancer Screening market. Mammography Screening, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Breast Magnetic Resonance Imaging (MRI) Screening segment is estimated at % CAGR for the next seven-year period.

Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Breast Cancer Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Breast Cancer Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Screening sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Breast Cancer Screening covered in this report include Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device and IMS Srl, etc.

The global Breast Cancer Screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Hologic
  • GE Healthcare
  • Siemen Healthineers
  • Philips Healthcare
  • Canon Medical
  • Fujifilm
  • Metaltronica
  • Sino Medical-Device
  • IMS Srl

Global Breast Cancer Screening market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Breast Cancer Screening market, Segment by Type:

  • Mammography Screening
  • Breast Magnetic Resonance Imaging (MRI) Screening
  • Breast Ultrasound Screening

Global Breast Cancer Screening market, by Application

  • Hospital
  • Clinic

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Breast Cancer Screening Market Overview
1.1 Breast Cancer Screening Product Overview
1.2 Breast Cancer Screening Market Segment by Type
1.2.1 Mammography Screening
1.2.2 Breast Magnetic Resonance Imaging (MRI) Screening
1.2.3 Breast Ultrasound Screening
1.3 Global Breast Cancer Screening Market Size by Type
1.3.1 Global Breast Cancer Screening Market Size Overview by Type (2018-2029)
1.3.2 Global Breast Cancer Screening Historic Market Size Review by Type (2018-2023)
1.3.3 Global Breast Cancer Screening Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Breast Cancer Screening Sales Breakdown by Type (2018-2023)
1.4.2 Europe Breast Cancer Screening Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Breast Cancer Screening Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Breast Cancer Screening Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Breast Cancer Screening Sales Breakdown by Type (2018-2023)
2 Global Breast Cancer Screening Market Competition by Company
2.1 Global Top Players by Breast Cancer Screening Sales (2018-2023)
2.2 Global Top Players by Breast Cancer Screening Revenue (2018-2023)
2.3 Global Top Players by Breast Cancer Screening Price (2018-2023)
2.4 Global Top Manufacturers Breast Cancer Screening Manufacturing Base Distribution, Sales Area, Product Type
2.5 Breast Cancer Screening Market Competitive Situation and Trends
2.5.1 Breast Cancer Screening Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Breast Cancer Screening Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2022)
2.7 Date of Key Manufacturers Enter into Breast Cancer Screening Market
2.8 Key Manufacturers Breast Cancer Screening Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Breast Cancer Screening Status and Outlook by Region
3.1 Global Breast Cancer Screening Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Breast Cancer Screening Historic Market Size by Region
3.2.1 Global Breast Cancer Screening Sales in Volume by Region (2018-2023)
3.2.2 Global Breast Cancer Screening Sales in Value by Region (2018-2023)
3.2.3 Global Breast Cancer Screening Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Breast Cancer Screening Forecasted Market Size by Region
3.3.1 Global Breast Cancer Screening Sales in Volume by Region (2024-2029)
3.3.2 Global Breast Cancer Screening Sales in Value by Region (2024-2029)
3.3.3 Global Breast Cancer Screening Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Breast Cancer Screening by Application
4.1 Breast Cancer Screening Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Breast Cancer Screening Market Size by Application
4.2.1 Global Breast Cancer Screening Market Size Overview by Application (2018-2029)
4.2.2 Global Breast Cancer Screening Historic Market Size Review by Application (2018-2023)
4.2.3 Global Breast Cancer Screening Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Breast Cancer Screening Sales Breakdown by Application (2018-2023)
4.3.2 Europe Breast Cancer Screening Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Breast Cancer Screening Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Breast Cancer Screening Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Breast Cancer Screening Sales Breakdown by Application (2018-2023)
5 North America Breast Cancer Screening by Country
5.1 North America Breast Cancer Screening Historic Market Size by Country
5.1.1 North America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Breast Cancer Screening Sales in Volume by Country (2018-2023)
5.1.3 North America Breast Cancer Screening Sales in Value by Country (2018-2023)
5.2 North America Breast Cancer Screening Forecasted Market Size by Country
5.2.1 North America Breast Cancer Screening Sales in Volume by Country (2024-2029)
5.2.2 North America Breast Cancer Screening Sales in Value by Country (2024-2029)
6 Europe Breast Cancer Screening by Country
6.1 Europe Breast Cancer Screening Historic Market Size by Country
6.1.1 Europe Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Breast Cancer Screening Sales in Volume by Country (2018-2023)
6.1.3 Europe Breast Cancer Screening Sales in Value by Country (2018-2023)
6.2 Europe Breast Cancer Screening Forecasted Market Size by Country
6.2.1 Europe Breast Cancer Screening Sales in Volume by Country (2024-2029)
6.2.2 Europe Breast Cancer Screening Sales in Value by Country (2024-2029)
7 Asia-Pacific Breast Cancer Screening by Region
7.1 Asia-Pacific Breast Cancer Screening Historic Market Size by Region
7.1.1 Asia-Pacific Breast Cancer Screening Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Breast Cancer Screening Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Breast Cancer Screening Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Breast Cancer Screening Forecasted Market Size by Region
7.2.1 Asia-Pacific Breast Cancer Screening Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Breast Cancer Screening Sales in Value by Region (2024-2029)
8 Latin America Breast Cancer Screening by Country
8.1 Latin America Breast Cancer Screening Historic Market Size by Country
8.1.1 Latin America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Breast Cancer Screening Sales in Volume by Country (2018-2023)
8.1.3 Latin America Breast Cancer Screening Sales in Value by Country (2018-2023)
8.2 Latin America Breast Cancer Screening Forecasted Market Size by Country
8.2.1 Latin America Breast Cancer Screening Sales in Volume by Country (2024-2029)
8.2.2 Latin America Breast Cancer Screening Sales in Value by Country (2024-2029)
9 Middle East and Africa Breast Cancer Screening by Country
9.1 Middle East and Africa Breast Cancer Screening Historic Market Size by Country
9.1.1 Middle East and Africa Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Breast Cancer Screening Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Breast Cancer Screening Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Breast Cancer Screening Forecasted Market Size by Country
9.2.1 Middle East and Africa Breast Cancer Screening Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Breast Cancer Screening Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Hologic
10.1.1 Hologic Company Information
10.1.2 Hologic Introduction and Business Overview
10.1.3 Hologic Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Hologic Breast Cancer Screening Products Offered
10.1.5 Hologic Recent Development
10.2 GE Healthcare
10.2.1 GE Healthcare Company Information
10.2.2 GE Healthcare Introduction and Business Overview
10.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GE Healthcare Breast Cancer Screening Products Offered
10.2.5 GE Healthcare Recent Development
10.3 Siemen Healthineers
10.3.1 Siemen Healthineers Company Information
10.3.2 Siemen Healthineers Introduction and Business Overview
10.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Siemen Healthineers Breast Cancer Screening Products Offered
10.3.5 Siemen Healthineers Recent Development
10.4 Philips Healthcare
10.4.1 Philips Healthcare Company Information
10.4.2 Philips Healthcare Introduction and Business Overview
10.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Philips Healthcare Breast Cancer Screening Products Offered
10.4.5 Philips Healthcare Recent Development
10.5 Canon Medical
10.5.1 Canon Medical Company Information
10.5.2 Canon Medical Introduction and Business Overview
10.5.3 Canon Medical Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Canon Medical Breast Cancer Screening Products Offered
10.5.5 Canon Medical Recent Development
10.6 Fujifilm
10.6.1 Fujifilm Company Information
10.6.2 Fujifilm Introduction and Business Overview
10.6.3 Fujifilm Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Fujifilm Breast Cancer Screening Products Offered
10.6.5 Fujifilm Recent Development
10.7 Metaltronica
10.7.1 Metaltronica Company Information
10.7.2 Metaltronica Introduction and Business Overview
10.7.3 Metaltronica Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Metaltronica Breast Cancer Screening Products Offered
10.7.5 Metaltronica Recent Development
10.8 Sino Medical-Device
10.8.1 Sino Medical-Device Company Information
10.8.2 Sino Medical-Device Introduction and Business Overview
10.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sino Medical-Device Breast Cancer Screening Products Offered
10.8.5 Sino Medical-Device Recent Development
10.9 IMS Srl
10.9.1 IMS Srl Company Information
10.9.2 IMS Srl Introduction and Business Overview
10.9.3 IMS Srl Breast Cancer Screening Sales, Revenue and Gross Margin (2018-2023)
10.9.4 IMS Srl Breast Cancer Screening Products Offered
10.9.5 IMS Srl Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Breast Cancer Screening Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Breast Cancer Screening Industrial Chain Analysis
11.4 Breast Cancer Screening Market Dynamics
11.4.1 Breast Cancer Screening Industry Trends
11.4.2 Breast Cancer Screening Market Drivers
11.4.3 Breast Cancer Screening Market Challenges
11.4.4 Breast Cancer Screening Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Breast Cancer Screening Distributors
12.3 Breast Cancer Screening Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock